Pain Blocking During Drug Administration or Blood Collection With Needles

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Montana Compton, University of California, Irvine
ClinicalTrials.gov Identifier:
NCT01166906
First received: July 20, 2010
Last updated: May 19, 2014
Last verified: May 2014
  Purpose

There is a gating mechanism in the dorsal horn of the spinal cord that acts to facilitate or inhibit transmission of pain signals to the brain. The gate can be closed by mechanical stimuli such as touch and vibration.


Condition Intervention
Pain, Intractable
Device: pain blocking

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pain Blocking During Drug Administration or Blood Collection With Needles

Further study details as provided by University of California, Irvine:

Primary Outcome Measures:
  • Pain Blocking During Drug Administration or Blood Collection With Needles [ Time Frame: up to 12 months ] [ Designated as safety issue: No ]
    Pain Blocking During Drug Administration or Blood Collection With Needles


Enrollment: 53
Study Start Date: March 2010
Study Completion Date: March 2014
Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: pain blocking
    pain blocking
Detailed Description:

The researcher develope a device that can use to reduce pain during drug administration or blood collection with needles.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

primary care clinic, community sample,

Criteria

Inclusion Criteria:

  • Receiving an injection with a needle
  • Able to score the pain on a scale of 0-10 using the universal pain assessment tool, preferably 7 years of age or older

Exclusion Criteria:

  • Current pregnancy
  • Inability to understand and carry out instruction
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01166906

Locations
United States, California
Beckman Laser Institute Medical clinic
Irvine, California, United States, 92612
Sponsors and Collaborators
Montana Compton
Investigators
Principal Investigator: Wangcun Jia, PhD Beckman Laser Institute University of California Irvine
  More Information

No publications provided

Responsible Party: Montana Compton, Administrative Nurse Research Coordinator Beckman Laser Institute, University of California, Irvine
ClinicalTrials.gov Identifier: NCT01166906     History of Changes
Other Study ID Numbers: NIH NIBIB;HS#2009-7245
Study First Received: July 20, 2010
Last Updated: May 19, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, Irvine:
pain blocking

Additional relevant MeSH terms:
Pain, Intractable
Nervous System Diseases
Neurologic Manifestations
Pain
Signs and Symptoms

ClinicalTrials.gov processed this record on October 20, 2014